Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | Chief Commercial Officer | March 03, 2025 | March 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date March 03, 2025 · Filed March 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,042 |
Reported balance
After 2025-03-03 transaction · row 1
1 source rowRow 1 · 2025-03-03 · Sale · Disposed 2,407 · Balance 36,042 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 23, 2022 Filed Aug 25, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,024 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-029753 · doc4.xml · derivative · entry 7 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,027 Underlying: Common Stock · 8,024 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 7,486 | $50.04 | $374,599.44 |
DisclosureSEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust Disclosed balance after: 27,290 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 8,024 | $50.04 | $401,520.96 |
DisclosureSEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.16, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 17:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 8,024 | $2.21 | $17,733.04 |
DisclosureSEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 18:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-028141 · doc4.xml · derivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,051 Underlying: Common Stock · 10,000 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 18:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 10,000 | $45.08 | $450,800.00 |
DisclosureSEC source: 0000899243-22-028141 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust Disclosed balance after: 34,776 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $45.00 to $45.40, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 18:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 10,000 | $45.16 | $451,600.00 |
DisclosureSEC source: 0000899243-22-028141 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 18:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 10,000 | $2.21 | $22,100.00 |
DisclosureSEC source: 0000899243-22-028141 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,823 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-027252 · doc4.xml · derivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,051 Underlying: Common Stock · 7,823 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,681 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-027252 · doc4.xml · derivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,681 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 13,504 | $40.01 | $540,295.04 |
DisclosureSEC source: 0000899243-22-027252 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.00 to $40.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 7,823 | $2.21 | $17,288.83 |
DisclosureSEC source: 0000899243-22-027252 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,681 | $0.28 | $1,590.68 |
DisclosureSEC source: 0000899243-22-027252 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 18:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,504 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-025481 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,681 Underlying: Common Stock · 13,504 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 18:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 13,504 | $35.06 | $473,450.24 |
DisclosureSEC source: 0000899243-22-025481 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.19, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 18:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 13,504 | $0.28 | $3,781.12 |
DisclosureSEC source: 0000899243-22-025481 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 17:48 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 52,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000899243-22-007684 · doc4.xml · derivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 18:25 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,941 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-035483 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,185 Underlying: Common Stock · 3,941 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 18:25 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,941 | $35.08 | $138,250.28 |
DisclosureSEC source: 0000899243-21-035483 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 18:25 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,941 | $0.28 | $1,103.48 |
DisclosureSEC source: 0000899243-21-035483 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 18:35 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,152 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-028859 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,126 Underlying: Common Stock · 5,152 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 18:35 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,152 | $35.10 | $180,835.20 |
DisclosureSEC source: 0000899243-21-028859 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.25, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 18:35 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,152 | $0.28 | $1,442.56 |
DisclosureSEC source: 0000899243-21-028859 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 17:39 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,899 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-026595 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,278 Underlying: Common Stock · 3,899 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 17:39 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,899 | $35.06 | $136,698.94 |
DisclosureSEC source: 0000899243-21-026595 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.18, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 17:39 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,899 | $0.28 | $1,091.72 |
DisclosureSEC source: 0000899243-21-026595 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · derivative · entry 9 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,177 Underlying: Common Stock · 20,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 20,000 | $32.00 | $640,000.00 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 6 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 20,000 | $0.28 | $5,600.00 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,452 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · derivative · entry 8 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,177 Underlying: Common Stock · 5,452 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,548 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · derivative · entry 7 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,548 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 14,217 | $31.09 | $442,006.53 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $31.54 to $31.80, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,783 | $30.45 | $176,092.35 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,293 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $30.54 to $31.52, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,452 | $0.28 | $1,526.56 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:36 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 14,548 | $0.39 | $5,673.72 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:48 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008448 · doc4.xml · derivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 27, 2020 Filed Mar 6, 2020 18:13 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy · Derivative | 50,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-20-007515 · doc4.xml · derivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 16:20 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-001634 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,548 Underlying: Common Stock · 5,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 16:20 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,000 | $20.02 | $100,100.00 |
DisclosureSEC source: 0000899243-20-001634 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 16:20 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,000 | $0.39 | $1,950.00 |
DisclosureSEC source: 0000899243-20-001634 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 18:51 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-19-021672 · doc4.xml · derivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,628 Underlying: Common Stock · 1,300 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 18:51 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,300 | $0.28 | $364.00 |
DisclosureSEC source: 0000899243-19-021672 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2019 Filed May 6, 2019 18:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 48,874 | Not disclosed Strike: $2.21 | Not disclosed |
DisclosureSEC source: 0000899243-19-012295 · doc4.xml · derivative · entry 10 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,874 Underlying: Common Stock · 48,874 shares Expires 2027-06-22 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| May 06, 2019 Filed May 6, 2019 18:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 171,061 | Not disclosed Strike: $0.63 | Not disclosed |
DisclosureSEC source: 0000899243-19-012295 · doc4.xml · derivative · entry 9 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,874 shares Expires 2027-06-22 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| May 06, 2019 Filed May 6, 2019 18:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 58,928 | Not disclosed Strike: $0.28 | Not disclosed |
DisclosureSEC source: 0000899243-19-012295 · doc4.xml · derivative · entry 8 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,928 Underlying: Common Stock · 58,928 shares Expires 2023-05-29 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 06, 2019 Filed May 6, 2019 18:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 206,250 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0000899243-19-012295 · doc4.xml · derivative · entry 7 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,928 shares Expires 2023-05-29 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 06, 2019 Filed May 6, 2019 18:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 19,548 | Not disclosed Strike: $0.39 | Not disclosed |
DisclosureSEC source: 0000899243-19-012295 · doc4.xml · derivative · entry 6 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,548 Underlying: Common Stock · 19,548 shares Expires 2021-09-27 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 06, 2019 Filed May 6, 2019 18:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 68,421 | Not disclosed Strike: $0.11 | Not disclosed |
DisclosureSEC source: 0000899243-19-012295 · doc4.xml · derivative · entry 5 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,548 shares Expires 2021-09-27 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 06, 2019 Filed May 6, 2019 18:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 882 | Not disclosed Strike: $57.75 | Not disclosed |
DisclosureSEC source: 0000899243-19-012295 · doc4.xml · derivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 882 Underlying: Common Stock · 882 shares Expires 2020-06-30 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 06, 2019 Filed May 6, 2019 18:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 3,088 | Not disclosed Strike: $16.50 | Not disclosed |
DisclosureSEC source: 0000899243-19-012295 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 882 shares Expires 2020-06-30 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.